USPTO serial 97033472
CALIFORNIA CLINICAL TRIALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- PEREZ, STEVEN M
- Law office
- TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CALIFORNIA CLINICAL TRIALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nathaniel T. Browand
NATHANIEL T. BROWAND MILBANK LLP55 HUDSON YARDSNEW YORK, NY 10001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Providing consulting services in the field of regulatory submission management, namely, assisting others in preparing applications for new drugs and medical devices with governmental regulatory bodies; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug and medical device approval; business consulting and management services in the field of clinical trials, namely, providing information management services, namely, the reporting of clinical research protocols and programs for pharmaceutical and device products | ACTIVE | — |
| 042 | Pharmaceutical and Scientific research and development services; Pharmaceutical products development; Pharmaceutical drug development services; Clinical research in the field of medicine, therapeutics and pharmaceutical development, namely, psychiatry, neurology, analgesia, metabolic diseases and disorders, endocrinology, dermatology, infectious diseases, and women's health; Conducting clinical trials for others; Drug discovery services; Consulting services in the field of pharmaceutical research and development; research and development services in the fields of psychiatry, neurology, analgesia, metabolic diseases and disorders, endocrinology, dermatology, infectious diseases, and women's health; consulting services for others in the field of design, planning, and implementation project management of clinical trials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 13, 2023 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 13, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 13, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 27, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 27, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 27, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 22, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 21, 2021 | NWAP | NEW APPLICATION ENTERED | — |